Max SCH (IFC-39444)

Countries
  • India
Geographic location where the impacts of the investment may be experienced.
Specific Location
Delhi
Whenever identified, the area within countries where the impacts of the investment may be experienced. Exact locations of projects may not be identified fully or at all in project documents. Please review updated project documents and community-led assessments.
Financial Institutions
  • International Finance Corporation (IFC)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Proposed
Stage of the project cycle. Stages vary by development bank and can include: pending, approval, implementation, and closed or completed.
Bank Risk Rating
B
Environmental and social categorization assessed by the development bank as a measure of the planned project’s environmental and social impacts. A higher risk rating may require more due diligence to limit or avoid harm to people and the environment. For example, "A" or "B" are risk categories where "A" represents the highest amount of risk. Results will include projects that specifically recorded a rating, all other projects are marked ‘U’ for "Undisclosed."
Voting Date
Jun 22, 2017
Date when project documentation and funding is reviewed by the Board for consideration and approval. Some development banks will state a "board date" or "decision date." When funding approval is obtained, the legal documents are accepted and signed, the implementation phase begins.
Borrower
MAX HEALTHCARE INSTITUTE LIMITED
A public entity (government or state-owned) provided with funds or financial support to manage and/or implement a project.
Sectors
  • Construction
  • Education and Health
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
Loan
The categories of the bank investment: loan, grant, guarantee, technical assistance, advisory services, equity and fund.
Investment Amount (USD)
$ 75.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Project Cost (USD)
$ 325.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Primary Source

Original disclosure @ IFC website

Updated in EWS Dec 8, 2017

Disclosed by Bank May 16, 2017

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
If provided by the financial institution, the Early Warning System Team writes a short summary describing the purported development objective of the project and project components. Review the complete project documentation for a detailed description.
This project funds the purchase of 49% of the Saket City Hospital Private Limited and general capital expansion of Max Healthcare Institute Limited. Affiliated with these medical companies are Max Smart Super Specialty Hospital and Gujarmal Modi Hospital and Research Centre for Medical Sciences. The locations of these companies are very close to each other and the Unit of Devki Devi Foundation and Max Healthcare Institute Limited plan to create a complex across that connects the hospitals with seven specialty centers.
People Affected By This Project
People Affected By This Project refers to the communities of people likely to be affected positively or negatively by a project.
1. Enhanced reach: MHIL, with 2,300 doctors in 14 hospitals across the country, is a critical part of the Indian healthcare infrastructure and establishment. The project will strengthen this institution in its patient outreach, particularly those in under-served markets in the Low Income States and northeastern states (presently about 25% of its in-patients and 28% out-patients are from these areas). As these hospitals expand and add beds and OPD services, there will be a proportionate increase in the free services available to Economically Weaker Section patients. 2. Raising the quality of healthcare nationwide: The proposed project will establish national centers of excellence to include a focus on neuro-sciences, transplants, oncology and cardiology, which are specialties where the standard and provision is not uniform across the country. Investments in critical healthcare infrastructure such as institutions like MHIL is necessary to ensure the population is adequately served. 3. Collaboration with the Government to provide quality healthcare: MHIL is already successfully running two tertiary care centers in Punjab, North India and also contemplating on opportunities to work with the Government to develop appropriate model under which a Government hospital can use MHIL's diagnostic facilities in the lean periods at pre-contracted rates and thus clear their backlogs which will help increase in patient outreach across all segments of the society including those of lower income group. 4. Skill development: As MHIL expands employment of more doctors and nurses would result in skill-training and addition to trained healthcare manpower in the country. MHIL has initiated a dialogue with several establishments to collaborate on training programs for medical administrators, nursing leaders and critical care nursing professionals.
Investment Description
Here you can find a list of individual development financial institutions that finance the project.
MHIL is a joint venture between Max India Limited (MIL) and Life Healthcare (LH), each party holding 45.95% in the Company. MIL is the listed entity for healthcare assets of the Max group and includes MHIL, Max Bupa (Health Insurance) and Antara (senior living). IFC holds a 3.1% stake in MIL and 7.5% stake in MHIL. The total Project cost is approximately US$ 325 million. The proposed IFC investment comprises subscription of up to INR 4875 million (US$75 million in Indian rupee equivalent terms) in secured Non-Convertible Debentures (NCDs) of MHIL.

Contact Information
This section aims to support the local communities and local CSO to get to know which stakeholders are involved in a project with their roles and responsibilities. If available, there may be a complaint office for the respective bank which operates independently to receive and determine violations in policy and practice. Independent Accountability Mechanisms receive and respond to complaints. Most Independent Accountability Mechanisms offer two functions for addressing complaints: dispute resolution and compliance review.
Max Healthcare Institute Limited Mr. Rakesh Kumar Prusti Director, Legal & Regulatory Affairs 0091 124 620 7777 (Ext. 7708) rakesh.prusti@maxhealthcare.com 7th floor, Tower A, DLF Center Court, DLF Phase V,Sec42,GolfCourse Road, Gurugram, Haryana 122022 www.maxhealthcare.in ACCOUNTABILITY MECHANISM OF IFC The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org. You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org/

How it works

How it works